La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Ispire Technology a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Ispire Technology..

Ispire Technology (NASDAQ:ISPR) Azioni, Catena delle Opzioni

Ispire Technology

Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.

Ispire Technology Inc

Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) has outperformed the market over the past 5 years by 10.38% on an annualized basis producing an average annual return of 24.26%. Currently, Goldman Sachs Group has a market capitalization of $188.74 billion. 
Buying $100 In GS: If an investor had bought $100 of GS stock 5 years ago, it would be worth $302.54 today based on a price of $604.85 for GS at the time of writing.
<h3>Goldman Sachs Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748551512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $100 Invested In Goldman Sachs Group 5 Years Ago Would Be Worth Today

Earnings

Earnings Misses

NGL Energy Partners Q4 EPS $(0.12) Misses $0.01 Estimate, Sales $971.07M Miss $1.35B Estimate

Castle Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>), a company improving health through innovative tests that guide patient care, will present novel research aimed at enhancing the clinical management of patients with cutaneous melanoma (CM) and uveal melanoma (UM) at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, being held May 30-June 3, 2025, in Chicago. This includes the latest findings from Castle's ongoing collaboration with the National Cancer Institute's Surveillance, Epidemiology and End Results (NCI's SEER) Program Registries affirming the significant, independent risk stratification provided by DecisionDx-Melanoma in an expanded, real-world cohort of more than 13,500 patients who received the test as part of their melanoma care.
"Management decisions for melanoma patients, such as referrals for sentinel lymph node biopsy and surveillance intensity, are guided by a patient's risk of dying from their disease," said Merve Hasanov, M.D., oncologist and director of the division of medical oncology at The Ohio State University Comprehensive Cancer Center in Columbus, Ohio. "The findings being presented at ASCO demonstrate that the DecisionDx-Melanoma test can provide more precise mortality risk predictions based on a patient's unique tumor biology and can improve upon the population-based risk assessment provided by American Joint Committee on Cancer (AJCC) staging. This can, in turn, help clinicians tailor treatment approaches to individual patient needs."
Castle's presentations at ASCO will take place during the Melanoma/Skin Cancers poster session on Sunday, June 1, from 9 a.m. to 12 p.m. Central time in Hall A – Posters and Exhibits.

Biotech

General

CSTL

Castle Biosciences Announces It Will Present Research Aimed At Enhancing The Clinical Management Of Patients With Cutaneous Melanoma And Uveal Melanoma At The 2025 American Society Of Clinical Oncology Annual Meeting

Costco Wholesale Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) reported third-quarter financial results after the market close on Thursday. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/05/g45681310/costco-wholesale-corporation-reports-third-quarter-and-year-to-date-operating-results-for-fiscal-2">from the report</a>.
Q3 Earnings: Costco reported third-quarter revenue of $63.2 billion, beating&nbsp;analyst <a href="http://benzinga.com/quote/COST/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $63.19 billion. The membership-based retailer reported third-quarter adjusted earnings of $4.28 per share, beating analyst estimates of $4.13 per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Net sales for the third quarter were up 8% year-over-year.&nbsp;Total comparable sales were up 5.7% on a year-over-year basis. Here&#8217;s a breakdown of comparable sales growth by region:
<ul class="wp-block-list">
<li>U.S.: up 6.6%</li>
</ul>
<ul class="wp-block-list">
<li>Canada: up 2.9%</li>
</ul>
<ul class="wp-block-list">
<li>Other International: up 3.2%</li>
</ul>
Membership fees came in at $1.24 billion, up from $1.12 billion in the prior year's quarter. Costco raised the price of its annual store membership by five dollars in September 2024, marking the company's first membership price hike since 2017.
Costco said it operates 905 warehouses, including 624 in the U.S. The company ended the quarter with approximately $13.84 billion in cash and cash equivalents.
Costco executives will further discuss the quarter on a conference call with investors and analysts at 5 p.m. ET.
COST Price Action: <a href="http://benzinga.com/quote/cost" target="_blank" rel="noreferrer noopener">Costco shares</a> were up 0.32% in after-hours, trading at $1,008.74 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45678353/these-analysts-revise-their-forecasts-on-dicks-sporting-goods-after-q1-results">These Analysts Revise Their Forecasts On Dick&#8217;s Sporting Goods After Q1 Results</a></li>
<li><a href="https://www.benzinga.com/personal-finance/25/05/45673001/tariff-confusion-creates-the-perfect-storm-for-cybercriminals-consumer-scams-on-the-rise">Tariff Confusion Creates The &#8216;Perfect Storm&#8217; For Cybercriminals, Consumer Scams On The Rise</a></li>
</ul>
Photo: Steve Travelguide/Shutterstock.

After-Hours Center

Movers

COST

Costco Q3 Earnings: Revenue Beat, EPS Beat, Comps Up 5.7%, Membership Fee Growth And More

Asset Sales

GATX

Wells Fargo To Sell Assets Of Rail Equipment Leasing Business To Joint Venture Between GATX And Brookfield Infrastructure Representing Book Value ~$4.4B As Well As Rail Finance Lease Portfolio

<ul>
<li>Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics</li>
<li>This partnership aims to create a framework for rapid diagnostics research, development and commercialization</li>
<li>Danaher, through its Centers for Enabling Precision Medicine, will provide support in all aspects of the development cycle across diagnostic modalities</li>
</ul>
WASHINGTON, May 29, 2025 /PRNewswire/ --&nbsp;Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) ("Danaher"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.
This partnership will utilize the newly opened Danaher Centers for Enabling Precision Medicine to support a more streamlined, end-to-end development process. The first product intended to be developed through this partnership will leverage technologies from Leica Biosystems, one of Danaher's subsidiaries. The initial focus will be on digital and computational pathology products and AI-assisted algorithms, to help clinicians better diagnose patients by identifying those who are most likely to benefit from targeted therapies.

Danaher Partners With AstraZeneca To Scale Precision Medicine, Including Developing Next Generation Of AI-Powered Diagnostics

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology
EMERYVILLE, Calif. and WESTCHESTER, Ill., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, and Ingredion Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>), a leading global provider of ingredient solutions to the food manufacturing industry, today announced an agreement to wind down their RealSweet joint venture. As part of the agreement, Amyris will assume 100% ownership of the Precision Fermentation Plant in Barra Bonita, Brazil, and Ingredion will exclusively utilize Amyris' technology to manufacture and commercialize fermented Reb M, setting the foundation for commercial success and future collaboration between the companies.

INGR

Amyris And Ingredion Agree To Wind Down RealSweet JV; Amyris Assumes Full Ownership Of Precision Fermentation Plant In Barra Bonita, Ingredion Gains Exclusive Reb M Rights

American Eagle Outfitters Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) shares are trading lower on Thursday in after-hours following the retailer&#8217;s report of weaker-than-expected financial results for the first quarter of<a href="https://www.benzinga.com/pressreleases/25/05/b45680850/aeo-inc-reports-first-quarter-fiscal-2025-results"> fiscal 2025. </a>
What To Know: The company posted a net loss of $64.9 million or 36 cents per share, missing analyst expectations of a 23 cents profit. Revenue came in at $1.09 billion, falling short of the $1.24 billion estimate.
The results were potentially driven by a 5% year-over-year revenue decline and a sharp contraction in gross margins, which dropped from 40.6% last year to 29.6% this quarter. The company cited inventory writedowns, higher product costs and deeper markdowns as key factors. Comparable sales declined 3% overall, with Aerie down 4% and the American Eagle brand down 2%.
In response, American Eagle provided second-quarter guidance projecting $40 to $45 million in operating income, with comparable sales expected to decline 3%. However, the company withheld full-year guidance, citing macroeconomic uncertainty and the need to reassess plans after the weak first quarter.
Despite the weak performance, the company is continuing a $200 million accelerated share repurchase program and has slightly reduced its full-year capital expenditure forecast from $300 million to $275 million.
AEO Price Action: American Eagle shares were down 7.78% at $10.31 after-hours Thursday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45662671/tesla-targets-june-12-for-robotaxi-launch-in-austin-elon-musk-says-company-ramped-up-fsd-testing-a-month-ahead-of-schedule">Tesla Targets June 12 For Robotaxi Launch In Austin, Elon Musk Says Company Ramped Up FSD Testing &#8216;A Month Ahead Of Schedule&#8217; </a></li>
</ul>
Image Via Shutterstock.

American Eagle Outfitters Shares Drop After Posting Disappointing Q1 Results

Contracts

NMAX

Newsmax Announces It Has Entered Into A Multi-Year Renewal For Distribution With Verizon Fios For Its Cable Channel Newsmax.

Yatra Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTRA#NASDAQ">YTRA</a>) reported quarterly losses of $(0.01) per share. This is a 66.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported $25.66 million in sales this quarter. This is a 113.87 percent increase over sales of $12.00 million the same period last year.

YTRA

Yatra Online Q1 Adj. EPS $(0.01) Up From $(0.03) YoY, Sales $25.66M Up From $12.00M YoY

WIIM

FEMY

Femasys shares are trading lower after the company announced a proposed public offering.

Cycurion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI,&nbsp;today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on May 22, 2025 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the "Form 10-Q"), as described more fully in the Company's Form NT 10-Q Notification of Late Filing (the "Form NT 10-Q") filed with the Securities and Exchange Commission (the "SEC") on May 15, 2025. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.

CYCU

Cycurion Receives Nasdaq Non-Compliance Notice Due To Delayed Quarterly Report

Offerings

DUOT

Duos Technologies Group Files Supplement To Prospectus Relating To Offer And Sale Of Up To $10.50M Of Stock Through At-The-Market Offering

Zeo Energy shares are trading lower after the company announced it received a Nasdaq late filing notice.

Management

XRAY

Dentsply Sirona Names Matthew E. Garth As CFO Effective May 30, 2025

MCHP

Microchip Technology shares are trading higher after the company raised its Q1 guidance.

You may be familiar with the adage, "Build a better mousetrap and the world will beat a path to your door," but have you ever heard of someone building a better mousetrap? Mark Sisson and Morgan Zanotti have done exactly that. They co-founded Primal Kitchen in 2015 by selling avocado-oil-based mayonnaise for $10 per jar. Four years later, they sold the company to Kraft Heinz (NASDAQ:<a href="https://www.benzinga.com/quote/KHC"> KHC</a>) for $200 million.&nbsp;
<a href="https://www.cnbc.com/video/2025/05/01/primal-kitchen-sold-to-kraft-heinz-for-200-million-how-it-started-up.html">CNBC</a> profiled their journey from startup to multi-millionaires, and there is a lot that everyday investors could learn from their story. Building a better mousetrap begins with the belief that there is a way to improve a product already on the market. In the case of Primal Kitchen, the product was mayonnaise. The popular spread is tasty, but notoriously high in fat and other ingredients that make it unhealthy to eat in large quantities.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
Sisson and Zanotti decided to change that. "At the time we launched Primal Kitchen, every condiment in the grocery store had either soybean, canola oil, sunflower seed oil, and or sugar," Zanotti told CNBC. Their decision to go with avocado oil made sense from a health perspective. Many nutritionists regard avocado as a "healthy fat," and a better alternative to saturated fats and oils, but avocados are expensive. That meant Primal Kitchen mayonnaise was going to be expensive.
&nbsp;"We launched in a category where the closest price competitor was probably like $3 per jar," Zanotti said. Sisson and Zanotti's avocado-oil-based mayonnaise would have a price point of $9.95 per jar, which is more than triple their most expensive competitor. "So many of our advisors in the food space said, ‘you're crazy, no one is going to spend $9.95 for a jar of mayonnaise,'" said Sisson.
The conventional wisdom that most consumers won't pay that much for mayonnaise is basically correct. However, Sisson and Zanotti did have a few factors working in their favor. First, there is a large contingent of consumers in the "better for you" segment of the food market. More importantly, they are willing to pay the price premium for healthier alternatives to everyday condiments like mayonnaise and salad dressing.
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a>
"We thought, look, we want this product. We're going to test the market and see if other people want it, and if they do great, we have a business. If not, we shut it down," Zanotti explained. That's where Primal Kitchen's other built-in advantages came into play. Sisson already had a successful supplements business that was generating enough revenue for him to divert profits into developing Primal Kitchen.&nbsp;
That also gave him a customer base with an affinity for health-conscious products. According to CNBC, Sisson<a href="https://www.benzinga.com/insights/news/25/05/45629928/100-invested-in-kkr-10-years-ago-would-be-worth-this-much-today"> invested</a> $2 million in profits from his supplement business to start Primal Kitchen. It was a risky gamble, but CNBC pointed out that the global condiment business was worth $31 billion annually and expected to continue growing in the years to come.&nbsp;
The CNBC profile noted Sisson's exploits in the food supplement and health industry included a successful blog with 3.5 million views per month and a book. "I spent ten years building a platform before I had a product," Sisson said, "It made it a lot easier to launch a product into that space." Ironically, Sisson met Zanotti in 2013 at an event for his fitness blog, and the two hit it off immediately.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
She had an extensive marketing background and a genuine commitment to Sisson's vision. After an initial attempt to launch Primal Kitchen with a professional chef failed, Sisson offered Zanotti the chance to bring her marketing expertise to the table and become his partner in Primal Kitchen. In addition to investing his own capital, Sisson also personally guaranteed a multi-million-dollar line of credit.
It was a risk, but Sisson and Zanotti believed in their vision and pressed ahead. The cost of buying enough avocados to supply Primal Kitchen was intense, and Sisson said the amount of credit he guaranteed often ran into the millions. "It was a combination of naivete and hubris that made me think we could launch this expensive mayonnaise," said Sisson.
Primal Kitchen introduced its avocado-based mayonnaise to the market in 2015, and it was a hit with both the health-conscious and paleo-diet community. According to CNBC, the company sold its first 12,000 units within one week. It went from there to high-end grocery store shelves and became a nationally known product within a year. The company broke even in year two with $26 million in sales and was doing $50 million annually by 2018.&nbsp;
That's when Sisson and Zanotti began looking for buyers. "I had always planned on growing this business to sell," said Sisson. "I was in my early 60s when I started the company."<a href="https://www.benzinga.com/news/25/05/45411513/kraft-heinz-bets-3-billion-on-us-factory-overhaul-to-offset-tariff-impact-report"> Kraft Heinz</a> was immediately interested and put in the winning bid of $200 million before sealing the deal in 2019. All parties involved in the transaction were thrilled with the outcome. According to CNBC, Primal Kitchen did nearly $250 million in sales in 2024.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

How Two Entrepreneurs Made $200 Million By Selling Mayonnaise For $10 Per Jar

RGTI

Rigetti Computing Files For Mixed Shelf Offering; No Size Or Amount Disclosed

BOWN

Bowen Acquisition Corp Receives Nasdaq Noncompliance Notification

<a href="https://www.frbsf.org/news-and-media/events/2025/05/a-conversation-on-the-economy-with-mary-c-daly/" title="https://www.frbsf.org/news-and-media/events/2025/05/a-conversation-on-the-economy-with-mary-c-daly/">https://www.frbsf.org/news-and-media/events/2025/05/a-conversation-on-the-economy-with-mary-c-daly/</a>

Macro Economic Events

Economics

Federal Reserve

Fed's Daly Says On Tariffs Don't Know Scope, Size Or Timing; Premature To Speculate How It Will Work Out; Businesses Say They Are Continuing To Do What They Do, But Taking Fewer Risks; Businesses Have Not Put Their Pencils Down; Fed Is 'Wait To See'; Expect To Continue To Bring Inflation Down, Labor Market Slowing But Solid; It's Not The First Time An Administration Has Asked Fed To Move Policy; Fed Is Accountable To Americans

Press Releases

/C O R R E C T I O N -- Ispire Technology Inc./

Ispire Technology Inc. Unveils Sprout™: The Future of All-in-One Vape Technology

Ispire Technology Inc. to Participate in the Planet MicroCap Showcase on April 23, 2025

IKE Tech Unveils Breakthrough Study Demonstrating 100% Effectiveness of First-Ever Blockchain-Based Age-Gating System for Electronic Nicotine Delivery Systems (ENDS)

IKE Tech Files First-Ever PMTA for Standalone Interoperable Blockchain-based Age-Gating System at Point of Use - Marking a New Chapter in Youth Vaping Prevention

Entertainment

Ispire Technology Advances Vapor Safety and Compliance With First-Ever FDA PMTA Filing for Blockchain-Powered Age-Gating System

Ispire Technologies Inc. Schedules Fiscal Third Quarter 2025 Earnings Conference Call

Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2025

Ispire Technology Inc. Announces Appointment of Jay Yu as Chief Financial Officer

Ispire Technology Inc. Announces Approval of Interim License for Manufacturing of Nicotine Products in Malaysia

ISPR

LKCOF

British American Tobacco Industries, p.l.c. Common Stock ADR

British American Tobacco

Altria Group

Philip Morris International Inc Common Stock

Philip Morris Intl

RLX Technology Inc. American Depositary Shares, each representing the right to receive one (1) Class A ordinary share

Comments

Ispire Technology

Ispire Technology (ISPR) Opzioni

Ispire Technology (NASDAQ:ISPR) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO